Biomarker Correlates of Response to Ciltacabtagene Autoleucel in Patients with Relapsed or Refractory Multiple Myeloma from CARTITUDE-1, a Phase 1b/2 Open-Label Study, at the ~3 Year Follow-up

Rocío Montes de, Enrique Zudaire, Deepu Madduri et al.|Blood|2023

Cited by 9